English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The discovery of the JAK2 and MPL mutations has been of enormous help in the diagnosis and characterization of chronic myeloproliferative disorders, and has opened new perspectives for targeted therapy. In this perspective article, Drs. Vannucchi and Guglielmelli review additional molecular mechanisms that may contribute to the pathogenesis of these disorders, such as aberrant expression of microRNA. See related papers on pages 1009 and 1098.

Molecular pathophysiology of Philadelphia-negative myeloproliferative disorders: beyond JAK2 and MPL mutations